BMRN vs. BMTX
BMRN (BioMarin Pharmaceutical Inc.) and BMTX (BM Technologies, Inc.) are both stocks. BMRN operates in Biotechnology (Healthcare), while BMTX operates in Software - Application (Technology).
Performance
BMRN vs. BMTX - Performance Comparison
Loading charts...
Returns By Period
BMRN
- 1D
- 2.51%
- 1M
- -1.44%
- YTD
- -8.03%
- 6M
- 0.64%
- 1Y
- -3.75%
- 3Y*
- -16.34%
- 5Y*
- -6.84%
- 10Y*
- -4.86%
BMTX
- 1D
- 0.00%
- 1M
- 0.00%
- YTD
- —
- 6M
- —
- 1Y
- —
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
BMRN vs. BMTX - Yearly Performance Comparison
| 2026 (YTD) | |
|---|---|
BMRN BioMarin Pharmaceutical Inc. | -5.97% |
BMTX BM Technologies, Inc. | 0.00% |
Fundamentals
BMRN:
$3.24B
BMTX:
$57.66M
BMRN:
$2.46B
BMTX:
$14.95M
BMRN:
$439.56M
BMTX:
-$6.70M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
BMRN vs. BMTX — Risk / Return Rank
BMRN
BMTX
BMRN vs. BMTX - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for BioMarin Pharmaceutical Inc. (BMRN) and BM Technologies, Inc. (BMTX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| BMRN | BMTX | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | — | — | |
| Sortino ratioReturn per unit of downside risk | — | — | |
| Omega ratioGain probability vs. loss probability | 1.01 | — | — |
| Calmar ratioReturn relative to maximum drawdown | -0.17 | — | — |
| Martin ratioReturn relative to average drawdown | -0.35 | — | — |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| BMRN | BMTX | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | -0.11 | — | — |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | -0.21 | — | — |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | -0.14 | — | — |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.11 | — | — |
Drawdowns
BMRN vs. BMTX - Drawdown Comparison
The maximum BMRN drawdown since its inception was -90.58%, which is greater than BMTX's maximum drawdown of 0.00%. Use the drawdown chart below to compare losses from any high point for BMRN and BMTX.
Loading charts...
Drawdown Indicators
| BMRN | BMTX | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -90.58% | 0.00% | -90.58% |
Max Drawdown (1Y)Largest decline over 1 year | -22.49% | — | — |
Max Drawdown (3Y)Largest decline over 3 years | -49.83% | — | — |
Max Drawdown (5Y)Largest decline over 5 years | -57.64% | — | — |
Max Drawdown (10Y)Largest decline over 10 years | -62.09% | — | — |
Current DrawdownCurrent decline from peak | -63.35% | 0.00% | -63.35% |
Average DrawdownAverage peak-to-trough decline | -45.51% | 0.00% | -45.51% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 10.84% | — | — |
Volatility
BMRN vs. BMTX - Volatility Comparison
Loading charts...
Volatility by Period
| BMRN | BMTX | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 15.30% | — | — |
Volatility (6M)Calculated over the trailing 6-month period | 27.79% | — | — |
Volatility (1Y)Calculated over the trailing 1-year period | 34.57% | 0.00% | +34.57% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 32.87% | 0.00% | +32.87% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 35.51% | 0.00% | +35.51% |
Dividends
BMRN vs. BMTX - Dividend Comparison
Neither BMRN nor BMTX has paid dividends to shareholders.
Financials
BMRN vs. BMTX - Financials Comparison
This section allows you to compare key financial metrics between BioMarin Pharmaceutical Inc. and BM Technologies, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Find the right allocation for BMRN and BMTX
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer